Continuous subcutaneous levodopa/carbidopa infusion with ND0612 for Parkinson's disease: Three-year data from the open-label BeyoND study.

Saved in:
Bibliographic Details
Title: Continuous subcutaneous levodopa/carbidopa infusion with ND0612 for Parkinson's disease: Three-year data from the open-label BeyoND study.
Authors: Stocchi, F.1 (AUTHOR), Poewe, W.2 (AUTHOR), Ellenbogen, A.3 (AUTHOR), Adar, L.4 (AUTHOR), Salin, L.4 (AUTHOR), Case, R.5 (AUTHOR), Yardeni, T.4 (AUTHOR), Giladi, N.6 (AUTHOR)
Source: Parkinsonism & Related Disorders. May2024, Vol. 122, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Description
ISSN:13538020
DOI:10.1016/j.parkreldis.2024.106147